A RCT of CenteringPregnancy on Birth Outcomes
CRADLE
Reducing Disparities in Birth Outcomes: a Randomized Controlled Trial of CenteringPregnancy
1 other identifier
interventional
2,350
1 country
4
Brief Summary
The purpose of this study is to evaluate whether CenteringPregnancy group prenatal care can improve preterm birth rate and other birth outcomes, maternal psychosocial and behavioral outcomes, and decrease the racial difference in selected birth outcomes among African American and White women, compared to individual prenatal care.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable pregnancy
Started Feb 2016
Longer than P75 for not_applicable pregnancy
4 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 20, 2015
CompletedFirst Posted
Study publicly available on registry
December 29, 2015
CompletedStudy Start
First participant enrolled
February 24, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 14, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
January 21, 2021
CompletedAugust 26, 2022
August 1, 2022
4.6 years
December 20, 2015
August 24, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Preterm birth
Delivery before 37 weeks gestation
Measured at delivery
Secondary Outcomes (6)
Birth weight
Measured at delivery
APGAR score
Measured at delivery
Gestational weight gain
Measured at delivery
Gestational diabetes incidence
Measured during pregnancy
Gestational hypertension
Measured during pregnancy
- +1 more secondary outcomes
Study Arms (2)
CenteringPregnancy group prenatal care
EXPERIMENTALPregnant women who were randomized to receive CenteringPregnancy group prenatal care
Traditional individual prenatal care
NO INTERVENTIONPregnant women who were randomized to receive traditional individual prenatal care
Interventions
8-12 pregnant women whose due dates are in the same month will receive ten 2-hour group prenatal care sessions according to the standard curriculum provided by the Centering Healthcare Institute.
Eligibility Criteria
You may qualify if:
- Pregnant women aged between 14-45 years
- Entry prenatal care before 20 6/7 weeks gestational age (defined as attendance at the intake screening visit). Patients must be randomized by 23 6/7 weeks gestational age.
You may not qualify if:
- Medical complications of pregnancy that would preclude prenatal care provision by nurse practitioners or participation in group care
- Pregestational diabetes,
- Severe chronic hypertension requiring medication,
- Morbid Obesity with BMI \>49.99
- Renal disease with baseline proteinuria \>1g/24 hours
- Any disease requiring chronic immunosuppression (SLE, solid organ transplant)
- Active pulmonary tuberculosis
- Sickle cell anemia
- Human Immunodeficiency Virus Infection
- Other medical conditions that would exclude women from group care at the discretion of the PI
- Pregnancy complications that would preclude prenatal care provision by nurse practitioners or participation in group care
- Multiple gestation
- Lethal fetal anomalies
- Other pregnancy complications that would exclude women from group care at the discretion of the PI
- Social and behavioral complications of pregnancy which would preclude prenatal care provision by nurse practitioners or participation in group care
- +2 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Clemson Universitylead
- Prisma Health-Upstatecollaborator
- University of California, Los Angelescollaborator
- Georgia State Universitycollaborator
Study Sites (4)
UCLA
Los Angeles, California, 90095, United States
Georgia State University
Atlanta, Georgia, 30303, United States
Clemson University
Clemson, South Carolina, 29634-0745, United States
Prisma Health
Greenville, South Carolina, 29605, United States
Related Publications (6)
Hsieh CT, Zhang L, Britt J, Shodahl S, Crockett A, Chen L. Pregnancy Anxiety and Risk of Gestational Diabetes Mellitus Among a Diverse U.S. Cohort. J Womens Health (Larchmt). 2025 Jan;34(2):206-213. doi: 10.1089/jwh.2024.0453. Epub 2024 Oct 17.
PMID: 39419550DERIVEDDoherty EA, Cartmell K, Griffin S, Heo M, Chen L, Britt JL, Crockett AH. Discrimination and Adverse Perinatal Health Outcomes: A Latent Class Analysis. Prev Chronic Dis. 2023 Nov 2;20:E96. doi: 10.5888/pcd20.230094.
PMID: 37917614DERIVEDKeenan-Devlin L, Miller GE, Ernst LM, Freedman A, Smart B, Britt JL, Singh L, Crockett AH, Borders A. Inflammatory markers in serum and placenta in a randomized controlled trial of group prenatal care. Am J Obstet Gynecol MFM. 2023 Dec;5(12):101200. doi: 10.1016/j.ajogmf.2023.101200. Epub 2023 Oct 22.
PMID: 37875178DERIVEDChen Y, Crockett AH, Britt JL, Zhang L, Nianogo RA, Qian T, Nan B, Chen L. Group vs Individual Prenatal Care and Gestational Diabetes Outcomes: A Secondary Analysis of a Randomized Clinical Trial. JAMA Netw Open. 2023 Aug 1;6(8):e2330763. doi: 10.1001/jamanetworkopen.2023.30763.
PMID: 37642966DERIVEDFrancis E, Johnstone MB, Convington-Kolb S, Witrick B, Griffin SF, Sun X, Crockett A, Chen L. Group Prenatal Care Attendance and Women's Characteristics Associated with Low Attendance: Results from Centering and Racial Disparities (CRADLE Study). Matern Child Health J. 2019 Oct;23(10):1371-1381. doi: 10.1007/s10995-019-02784-7.
PMID: 31236826DERIVEDChen L, Crockett AH, Covington-Kolb S, Heberlein E, Zhang L, Sun X. Centering and Racial Disparities (CRADLE study): rationale and design of a randomized controlled trial of centeringpregnancy and birth outcomes. BMC Pregnancy Childbirth. 2017 Apr 13;17(1):118. doi: 10.1186/s12884-017-1295-7.
PMID: 28403832DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Moonseong Heo, PhD
Clemson University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Contact Principal Investigator
Study Record Dates
First Submitted
December 20, 2015
First Posted
December 29, 2015
Study Start
February 24, 2016
Primary Completion
October 14, 2020
Study Completion
January 21, 2021
Last Updated
August 26, 2022
Record last verified: 2022-08
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF
- Time Frame
- Deidentified study data will be available publicly on the NICHD/DASH Data and Specimen Hub (https://dash.nichd.nih.gov/) in October 2026, five years after study completion.
- Access Criteria
- Requestors will need to sign a data access agreement.
Deidentified study data will be available publicly on the NICHD/DASH Data and Specimen Hub (https://dash.nichd.nih.gov/) in October 2026, five years after study completion. Prior to that time, researchers with a methodologically sound proposal can direct inquiries to amy.crockett@prismahealth.org to gain access to the study protocol, informed consent forms, deidentified data, data dictionaries and the analytic plan. Requestors will need to sign a data access agreement.